Prognostic value of Platelet-to-lymphocyte ratio in hospitalized patients with COVID-19 pneumonia
N. Boubaker (Tunis, Tunisia), I. Mejri (Tunis, Tunisia), N. Guediri (Tunis, Tunisia), S. Daboussi (Tunis, Tunisia), S. M'Hamdi (Tunis, Tunisia), C. Aichaouia (Tunis, Tunisia), K. Ayed (Tunis, Tunisia), Z. Moetemri (Tunis, Tunisia)
Source: International Congress 2022 – Biomarkers in COVID
Session: Biomarkers in COVID
Session type: Thematic Poster
Number: 354
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Boubaker (Tunis, Tunisia), I. Mejri (Tunis, Tunisia), N. Guediri (Tunis, Tunisia), S. Daboussi (Tunis, Tunisia), S. M'Hamdi (Tunis, Tunisia), C. Aichaouia (Tunis, Tunisia), K. Ayed (Tunis, Tunisia), Z. Moetemri (Tunis, Tunisia). Prognostic value of Platelet-to-lymphocyte ratio in hospitalized patients with COVID-19 pneumonia. 354
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|